<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Neonatal Severe Encephalopathy with Lactic Acidosis and Brain Abnormalities - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
            --banner-bg: #fef3c7;
            --banner-border: #f59e0b;
            --banner-text: #92400e;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .notice-banner {
            background: var(--banner-bg);
            color: var(--banner-text);
            border-bottom: 1px solid var(--banner-border);
            padding: 12px 16px;
            text-align: center;
            font-size: 0.95rem;
            cursor: pointer;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-location {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-component {
            background: #f0fdf4;
            color: #166534;
        }

        .tag-complex {
            background: #faf5ff;
            color: #7e22ce;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Phenotype TOC strip */
        .pheno-toc {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #e2e8f0;
            margin-bottom: 4px;
        }

        .pheno-toc-pill {
            display: inline-block;
            font-size: 0.78rem;
            padding: 3px 10px;
            border-radius: 12px;
            background: #dcfce7;
            color: #166534;
            text-decoration: none;
            cursor: pointer;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toc-pill:hover {
            background: #bbf7d0;
        }

        .pheno-toc-pill .pill-count {
            font-weight: 600;
            margin-left: 2px;
        }

        .pheno-toggle-all {
            font-size: 0.78rem;
            color: #16a34a;
            cursor: pointer;
            background: none;
            border: 1px solid #bbf7d0;
            border-radius: 6px;
            padding: 3px 10px;
            margin-left: auto;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toggle-all:hover {
            background: #f0fdf4;
        }

        /* Collapsible category groups */
        .phenotype-category-group {
            margin-bottom: 2px;
        }

        .phenotype-category-group summary {
            font-size: 0.85rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #16a34a;
            margin: 0;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #bbf7d0;
            cursor: pointer;
            list-style: none;
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .phenotype-category-group summary::-webkit-details-marker {
            display: none;
        }

        .phenotype-category-group summary .chevron {
            display: inline-block;
            width: 16px;
            height: 16px;
            transition: transform 0.15s;
            flex-shrink: 0;
        }

        .phenotype-category-group[open] summary .chevron {
            transform: rotate(90deg);
        }

        .phenotype-category-group summary .cat-count {
            font-size: 0.75rem;
            font-weight: 400;
            color: #15803d;
            background: #dcfce7;
            padding: 1px 7px;
            border-radius: 8px;
        }

        /* Phenotype Contexts */
        .phenotype-contexts {
            margin-top: 10px;
        }

        .phenotype-contexts-toggle {
            font-size: 0.8rem;
            color: var(--text-muted);
            cursor: pointer;
            user-select: none;
        }

        .phenotype-contexts-toggle:hover {
            color: var(--primary);
        }

        .context-card {
            padding: 10px 14px;
            margin-top: 8px;
            border-radius: 8px;
            background: #ecfdf5;
            border: 1px solid #a7f3d0;
            font-size: 0.88rem;
        }

        .context-header {
            display: flex;
            flex-wrap: wrap;
            align-items: center;
            gap: 6px;
            margin-bottom: 6px;
        }

        .context-label {
            font-size: 0.72rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            padding: 2px 8px;
            border-radius: 4px;
        }

        .context-label-genetic {
            background: #dbeafe;
            color: #1e40af;
        }

        .context-label-sex {
            background: #fce7f3;
            color: #9d174d;
        }

        .context-label-population {
            background: #fef3c7;
            color: #92400e;
        }

        .context-label-age {
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-label-subtype {
            background: #ede9fe;
            color: #5b21b6;
        }

        .context-label-frequency {
            background: #dcfce7;
            color: #166534;
        }

        .context-gene-list {
            display: flex;
            flex-wrap: wrap;
            gap: 4px;
            margin: 4px 0;
        }

        .context-gene-tag {
            font-size: 0.78rem;
            font-weight: 600;
            padding: 1px 8px;
            border-radius: 4px;
            background: #bfdbfe;
            color: #1e3a8a;
        }

        .context-detail {
            font-size: 0.84rem;
            color: #065f46;
            line-height: 1.5;
        }

        .context-detail strong {
            color: #047857;
        }

        .context-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #bbf7d0;
            color: #14532d;
            font-weight: 600;
        }

        .context-onset {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-severity {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #fef3c7;
            color: #92400e;
        }

        .context-notes {
            font-size: 0.84rem;
            color: #065f46;
            margin-top: 4px;
            line-height: 1.5;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }
        .classification-header {
            font-size: 1rem;
            font-weight: 600;
            color: #4338ca;
            margin: 1.2rem 0 0.5rem 0;
            padding-bottom: 0.3rem;
            border-bottom: 2px solid #c7d2fe;
            text-transform: capitalize;
        }
        .subtype-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 0.4rem;
            margin: 0.3rem 0;
        }
        .subtype-freq-badge {
            background: #dbeafe;
            color: #1e40af;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-gene-tag {
            background: #fef3c7;
            color: #92400e;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-inheritance-tag {
            background: #ede9fe;
            color: #5b21b6;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-term-link {
            font-size: 0.8rem;
            color: #6366f1;
            text-decoration: none;
        }
        .subtype-term-link:hover { text-decoration: underline; }
        .subtype-children {
            margin: 0.4rem 0 0.2rem 1rem;
            padding: 0;
            list-style: none;
        }
        .subtype-children li {
            font-size: 0.85rem;
            color: #4338ca;
            padding: 0.1rem 0;
        }
        .subtype-children li::before {
            content: "â†³ ";
            color: #a5b4fc;
        }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="notice-banner" role="button" tabindex="0">This resource is in its pre-alpha development stage. Content is actively being curated and may be incomplete or subject to change.</div>
    

    

    
    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Neonatal Severe Encephalopathy with Lactic Acidosis and Brain Abnormalities</span>
        </nav>

        <header class="page-header">
            <h1>Neonatal Severe Encephalopathy with Lactic Acidosis and Brain Abnormalities</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Mendelian</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0060562" target="_blank">
                        MONDO:0060562
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Mitochondrial lipoylation defect</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Neonatal encephalopathy</span>
                
            </div>
            
            <p style="margin-top: 16px; font-size: 1rem; line-height: 1.6; opacity: 0.95; position: relative;">
                NELABA (Encephalopathy, Neonatal Severe, with Lactic Acidosis and Brain Abnormalities; OMIM 617668) is an ultra-rare autosomal recessive mitochondrial disorder caused by biallelic mutations in LIPT2, encoding lipoyltransferase 2. LIPT2 catalyzes the first committed step in the mitochondrial lipoylation pathway, transferring octanoyl groups from acyl carrier protein to the glycine cleavage system H protein (GCSH). Loss of function impairs lipoylation of all lipoic acid-dependent enzyme complexes: pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain ketoacid dehydrogenase, and the glycine cleavage system. This causes congenital lactic acidosis, hyperglycinemia, severe encephalopathy with minimal psychomotor development, and progressive brain abnormalities including cortical atrophy, cysts, white matter abnormalities, and cortical malformations. Onset is at birth with hypotonia and respiratory insufficiency. Only four cases have been reported. Prognosis is poor; lipoic acid supplementation is ineffective.

            </p>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Definitions</div>
            </div>
            
            
            <a class="stat-link" href="#inheritance">
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Inheritance</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Pathophysiology</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">14</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#genetic">
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Genes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">2</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
            
        </div>

        <!-- Classifications -->
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        

        <!-- Inheritance -->
        
        <div class="card" id="inheritance">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #92400e;">ðŸ‘ª</div>
                <h2 class="card-title">Inheritance</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box inheritance-box">
                <div class="item-name">
                    Autosomal recessive
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0000007" target="_blank">
                            HP:0000007
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">NELABA follows autosomal recessive inheritance. Affected individuals carry biallelic (homozygous or compound heterozygous) loss-of-function mutations in LIPT2. Three initial patients from two families were reported with compound heterozygous mutations.
</div>
                
                
    
    
    <div class="item-meta">
        
        <span class="tag tag-classification">
            Autosomal recessive inheritance
        </span>
        
        
        
        
        
    </div>
    
    
    
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28757203" target="_blank">PMID:28757203</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"We report on the identification of biallelic LIPT2 mutations in three affected individuals from two families with severe neonatal encephalopathy."</div>
                
                
                <div class="evidence-explanation">Establishes autosomal recessive inheritance pattern with biallelic mutations in two unrelated families.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Subtypes -->
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">âš™</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Impaired mitochondrial lipoylation via LIPT2 deficiency</div>
                
                <div class="item-desc">LIPT2 encodes lipoyltransferase 2, which transfers octanoyl groups from octanoyl-ACP (synthesized by the mitochondrial fatty acid synthesis system) to the glycine cleavage system H protein (GCSH). This is the first committed step in the mitochondrial lipoylation pathway. The octanoyl-GCSH is then converted to lipoyl-GCSH by lipoic acid synthetase (LIAS), and LIPT1 relays lipoyl groups from GCSH to the E2 subunits of alpha-ketoacid dehydrogenases. Loss-of-function mutations in LIPT2 abolish this initial transfer, leading to deficient lipoylation of all lipoic acid-dependent enzyme complexes and disruption of the glycine cleavage system. Unlike LIPT1 deficiency which spares glycine cleavage, LIPT2 deficiency affects all lipoylated proteins.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Neuron
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000540" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-gene">
                        LIPT2
                        
                        <a href="https://bioregistry.io/hgnc:37216" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Protein lipoylation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0009249" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28757203" target="_blank">PMID:28757203</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Affected individuals&#39; fibroblasts showed reduced oxygen consumption rates, PDHc, Î±-KGDHc activities, leucine catabolic flux, and decreased protein lipoylation."</div>
                
                
                <div class="evidence-explanation">Demonstrates that LIPT2 mutations cause decreased protein lipoylation and impaired function of multiple mitochondrial enzyme complexes in patient fibroblasts.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28757203" target="_blank">PMID:28757203</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-IN_VITRO">In Vitro</span>
                    
                </div>
                
                <div class="evidence-snippet">"A normalization of lipoylation was observed after expression of wild-type LIPT2, arguing for LIPT2 requirement in intramitochondrial lipoate synthesis."</div>
                
                
                <div class="evidence-explanation">Wild-type LIPT2 complementation rescues lipoylation defect, confirming LIPT2 as the causative gene.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32508887" target="_blank">PMID:32508887</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-COMPUTATIONAL">Computational</span>
                    
                </div>
                
                <div class="evidence-snippet">"LIPT2 utilizes octanoyl-ACP synthesized by the mitochondrial fatty acid synthesis system to modify GCSH."</div>
                
                
                <div class="evidence-explanation">Review defining the biochemical role of LIPT2 as the enzyme that transfers octanoyl groups to the glycine cleavage system H protein.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Combined alpha-ketoacid dehydrogenase deficiency</div>
                
                <div class="item-desc">Defective lipoylation of the E2 subunits of pyruvate dehydrogenase (PDHc), alpha-ketoglutarate dehydrogenase (alpha-KGDHc), and branched-chain ketoacid dehydrogenase (BCKDHc) impairs oxidative metabolism of pyruvate, alpha-ketoglutarate, and branched-chain amino acids. Loss of PDHc blocks entry of glycolytic end products into the TCA cycle, causing pyruvate and lactate accumulation and energy failure. Loss of alpha-KGDHc disrupts the TCA cycle at its midpoint. The brain is particularly vulnerable due to its high dependence on oxidative metabolism.
</div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Pyruvate dehydrogenase complex
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0045254" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        Tricarboxylic acid cycle
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006099" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32508887" target="_blank">PMID:32508887</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-COMPUTATIONAL">Computational</span>
                    
                </div>
                
                <div class="evidence-snippet">"The loss of these two dehydrogenases short-circuits the citric acid cycle, resulting in severe respiratory deficiency and extreme muscle weakness"</div>
                
                
                <div class="evidence-explanation">Review explaining how loss of PDHc and alpha-KGDHc disrupts the citric acid cycle and causes the clinical phenotype.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32508887" target="_blank">PMID:32508887</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-COMPUTATIONAL">Computational</span>
                    
                </div>
                
                <div class="evidence-snippet">"Patients that display absent or low lipoylation of all three enzymes have mutations in either of two genes LIAS or LIPT2"</div>
                
                
                <div class="evidence-explanation">Confirms that LIPT2 mutations affect all three lipoylated enzyme complexes.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Glycine cleavage system dysfunction</div>
                
                <div class="item-desc">Unlike LIPT1 deficiency which spares the glycine cleavage system, LIPT2 deficiency impairs lipoylation of GCSH itself, leading to defective glycine cleavage and elevated glycine levels. Glycine accumulation in the brain contributes to neurological impairment including seizures and encephalopathy.
</div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Glycine cleavage complex
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0005960" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28757203" target="_blank">PMID:28757203</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Plasma glycine was mildly increased."</div>
                
                
                <div class="evidence-explanation">Demonstrates that LIPT2 deficiency impairs the glycine cleavage system, unlike LIPT1 deficiency.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32508887" target="_blank">PMID:32508887</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-COMPUTATIONAL">Computational</span>
                    
                </div>
                
                <div class="evidence-snippet">"Lack of glycine cleavage activity additionally results in elevated brain glycine levels which can result in a host of neurological disorders, including neurodegeneration, encephalopathy, and neonatal-onset epilepsy"</div>
                
                
                <div class="evidence-explanation">Review explaining the neurological consequences of impaired glycine cleavage in lipoylation defects.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Brain glycine accumulation with NMDA receptor overactivation</div>
                
                <div class="item-desc">Impaired glycine cleavage elevates CNS glycine, which can potentiate excitatory neurotransmission through NMDA receptor co-agonism and increase cortical network hyperexcitability. This provides a mechanistic bridge from glycine cleavage dysfunction to neonatal seizures.
</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32508887" target="_blank">PMID:32508887</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-COMPUTATIONAL">Computational</span>
                    
                </div>
                
                <div class="evidence-snippet">"Lack of glycine cleavage activity additionally results in elevated brain glycine levels which can result in a host of neurological disorders, including neurodegeneration, encephalopathy, and neonatal-onset epilepsy"</div>
                
                
                <div class="evidence-explanation">Supports elevated brain glycine as the proximal driver of neurologic dysfunction, including epilepsy, in lipoylation defects.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">â¬¡</div>
                <h2 class="card-title">Causal Graph</h2>
            </div>
            
            <div class="mermaid-container">
                <pre class="mermaid">graph LR
    Seizures[&#34;Seizures&#34;]
    Combined_alpha_ketoacid_dehydrogenase_deficiency[&#34;Combined alpha-ketoacid dehydrogenase deficiency&#34;]
    Global_developmental_delay[&#34;Global developmental delay&#34;]
    Glycine_cleavage_system_dysfunction[&#34;Glycine cleavage system dysfunction&#34;]
    Impaired_mitochondrial_lipoylation_via_LIPT2_deficiency[&#34;Impaired mitochondrial lipoylation via LIPT2 deficiency&#34;]
    Lactic_acidosis[&#34;Lactic acidosis&#34;]
    Hyperglycinemia[&#34;Hyperglycinemia&#34;]
    Brain_glycine_accumulation_with_NMDA_receptor_overactivation[&#34;Brain glycine accumulation with NMDA receptor overactivation&#34;]

    Impaired_mitochondrial_lipoylation_via_LIPT2_deficiency --&gt; Combined_alpha_ketoacid_dehydrogenase_deficiency
    Impaired_mitochondrial_lipoylation_via_LIPT2_deficiency --&gt; Glycine_cleavage_system_dysfunction
    Combined_alpha_ketoacid_dehydrogenase_deficiency --&gt; Lactic_acidosis
    Combined_alpha_ketoacid_dehydrogenase_deficiency --&gt; Global_developmental_delay
    Glycine_cleavage_system_dysfunction --&gt; Hyperglycinemia
    Glycine_cleavage_system_dysfunction --&gt; Brain_glycine_accumulation_with_NMDA_receptor_overactivation
    Brain_glycine_accumulation_with_NMDA_receptor_overactivation --&gt; Seizures

    style Seizures fill:#fef3c7
    style Combined_alpha_ketoacid_dehydrogenase_deficiency fill:#dbeafe
    style Global_developmental_delay fill:#fef3c7
    style Glycine_cleavage_system_dysfunction fill:#dbeafe
    style Impaired_mitochondrial_lipoylation_via_LIPT2_deficiency fill:#dbeafe
    style Lactic_acidosis fill:#fef3c7
    style Hyperglycinemia fill:#fef3c7
    style Brain_glycine_accumulation_with_NMDA_receptor_overactivation fill:#dbeafe</pre>
            </div>
        </div>
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">â—</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">14</span>
            </div>
            
            
            <div class="pheno-toc">
                
                <a class="pheno-toc-pill" data-target="pheno-cat-1">Digestive<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-2">Head and Neck<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-3">Metabolism<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-4">Musculoskeletal<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-5">Nervous System<span class="pill-count">(7)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-6">Respiratory<span class="pill-count">(1)</span></a>
                
                <button class="pheno-toggle-all" id="phenoToggleAll">Expand all</button>
            </div>
            
            
            <details class="phenotype-category-group" id="pheno-cat-1">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Digestive
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Feeding difficulties
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0008872" target="_blank">
                                Feeding difficulties in infancy
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0008872)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39536593" target="_blank">PMID:39536593</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The patient was a 15-month-old female who presented at one month with dystonia, developmental delay, and feeding difficulties."</div>
                
                
                <div class="evidence-explanation">Feeding difficulties reported in the fourth case.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-2">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Head and Neck
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Microcephaly
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000252" target="_blank">
                                Microcephaly
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000252)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-3">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Metabolism
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Lactic acidosis
                        
                        <span class="phenotype-freq">OBLIGATE</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0004902" target="_blank">
                                Congenital lactic acidosis
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0004902)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39536593" target="_blank">PMID:39536593</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Patient had elevations in lactate (6.1 mmol/L) and glycine."</div>
                
                
                <div class="evidence-explanation">Fourth reported case confirms lactic acidosis as a consistent feature with quantified lactate elevation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Hyperglycinemia
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002154" target="_blank">
                                Hyperglycinemia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002154)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28757203" target="_blank">PMID:28757203</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Plasma glycine was mildly increased."</div>
                
                
                <div class="evidence-explanation">Elevated glycine reflects impaired glycine cleavage system lipoylation in LIPT2 deficiency.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39536593" target="_blank">PMID:39536593</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Patient had elevations in lactate (6.1 mmol/L) and glycine."</div>
                
                
                <div class="evidence-explanation">Fourth case confirms glycine elevation as a biochemical marker of LIPT2 deficiency.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-4">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Musculoskeletal
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Neonatal hypotonia
                        
                        <span class="phenotype-freq">OBLIGATE</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001319" target="_blank">
                                Neonatal hypotonia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001319)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28757203" target="_blank">PMID:28757203</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"three affected individuals from two families with severe neonatal encephalopathy"</div>
                
                
                <div class="evidence-explanation">All reported patients presented with severe neonatal encephalopathy including hypotonia.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Spasticity
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001257" target="_blank">
                                Spasticity
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001257)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-5">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Nervous System
                    <span class="cat-count">7</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Seizures
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001250" target="_blank">
                                Seizure
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001250)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28757203" target="_blank">PMID:28757203</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"three affected individuals from two families with severe neonatal encephalopathy"</div>
                
                
                <div class="evidence-explanation">Seizures are part of the severe neonatal encephalopathy described in the index patients.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Cerebral atrophy
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002059" target="_blank">
                                Cerebral atrophy
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002059)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28757203" target="_blank">PMID:28757203</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Brain MRI showed major cortical atrophy with white matter abnormalities and cysts."</div>
                
                
                <div class="evidence-explanation">Brain MRI in the index patients demonstrated cortical atrophy as a consistent feature.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Dystonia
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001332" target="_blank">
                                Dystonia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001332)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39536593" target="_blank">PMID:39536593</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Unlike most neurometabolic disorders where dystonia develops later after metabolic stroke in basal ganglia, LIPT2-related disorder seems unique due to early onset of dystonia due to energy deficit in the developing brain."</div>
                
                
                <div class="evidence-explanation">The fourth reported case highlights early-onset dystonia as a distinctive feature of LIPT2 deficiency.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Delayed myelination
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0012448" target="_blank">
                                Delayed myelination
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0012448)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Global developmental delay
                        
                        <span class="phenotype-freq">OBLIGATE</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0012736" target="_blank">
                                Profound global developmental delay
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0012736)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39536593" target="_blank">PMID:39536593</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The patient was a 15-month-old female who presented at one month with dystonia, developmental delay, and feeding difficulties."</div>
                
                
                <div class="evidence-explanation">Developmental delay is a universal feature across all reported LIPT2 patients.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Abnormal cerebral white matter morphology
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002500" target="_blank">
                                Abnormal cerebral white matter morphology
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002500)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28757203" target="_blank">PMID:28757203</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Brain MRI showed major cortical atrophy with white matter abnormalities and cysts."</div>
                
                
                <div class="evidence-explanation">Brain MRI in index patients demonstrated white matter abnormalities as a consistent feature.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Polymicrogyria
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002126" target="_blank">
                                Polymicrogyria
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002126)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39536593" target="_blank">PMID:39536593</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Brain magnetic resonance imaging showed cortical malformations including colpocephaly, polymicrogyria, and heterotopia."</div>
                
                
                <div class="evidence-explanation">Brain MRI in the fourth case revealed cortical malformations not previously described in LIPT2 deficiency.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-6">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Respiratory
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Respiratory insufficiency
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002093" target="_blank">
                                Respiratory insufficiency
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002093)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <script>
            (function() {
                // TOC pill click: expand target group and scroll to it
                document.querySelectorAll('.pheno-toc-pill').forEach(function(pill) {
                    pill.addEventListener('click', function() {
                        var target = document.getElementById(pill.dataset.target);
                        if (target) {
                            target.open = true;
                            target.scrollIntoView({behavior: 'smooth', block: 'start'});
                        }
                    });
                });
                // Expand/collapse all toggle
                var btn = document.getElementById('phenoToggleAll');
                if (btn) {
                    btn.addEventListener('click', function() {
                        var groups = document.querySelectorAll('.phenotype-category-group');
                        var anyOpen = Array.from(groups).some(function(g) { return g.open; });
                        groups.forEach(function(g) { g.open = !anyOpen; });
                        btn.textContent = anyOpen ? 'Expand all' : 'Collapse all';
                    });
                }
            })();
            </script>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card" id="genetic">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">ðŸ§¬</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    LIPT2 loss-of-function variants
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Causative)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28757203" target="_blank">PMID:28757203</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"We report on the identification of biallelic LIPT2 mutations in three affected individuals from two families with severe neonatal encephalopathy."</div>
                
                
                <div class="evidence-explanation">Index report identifying LIPT2 as the causative gene through exome sequencing in two families.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39536593" target="_blank">PMID:39536593</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Exome sequencing showed two variants of uncertain significance in trans in the LIPT2 gene: c.346 G&gt;T and c.418C&gt;T."</div>
                
                
                <div class="evidence-explanation">Fourth case identifies novel LIPT2 variants confirmed by yeast complementation.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39536593" target="_blank">PMID:39536593</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"Yeast complementation experiments indicate that both patient mutant variants result in diminished function versions of the LIPT2 protein."</div>
                
                
                <div class="evidence-explanation">Functional validation of novel LIPT2 variants in yeast model confirms pathogenicity.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">ðŸ’Š</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Supportive care
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000950" target="_blank">
                            MAXO:0000950
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Management is primarily supportive, including ventilatory support, anticonvulsant therapy, and nutritional supplementation. No disease-modifying therapy is currently available.
</div>
                
                
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Lipoic acid supplementation (ineffective)
                    
                </div>
                
                
                <div class="item-desc">Lipoic acid supplementation has been attempted in LIPT2 patients and in yeast models but proved ineffective, consistent with the inability of exogenous lipoate to be incorporated into the mitochondrial lipoylation pathway in mammals.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28757203" target="_blank">PMID:28757203</a>
                    </span>
                    
                    <span class="evidence-support support-REFUTE">REFUTE</span>
                    
                    
                    <span class="evidence-source source-IN_VITRO">In Vitro</span>
                    
                </div>
                
                <div class="evidence-snippet">"Lipoic acid supplementation did not improve clinical condition nor activities of PDHc, Î±-KGDHc, or leucine metabolism in fibroblasts and was ineffective in yeast deleted for the orthologous LIP2."</div>
                
                
                <div class="evidence-explanation">Demonstrates that lipoic acid supplementation does not rescue the enzymatic defects in LIPT2 deficiency, either in patient fibroblasts or in yeast models.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39536593" target="_blank">PMID:39536593</a>
                    </span>
                    
                    <span class="evidence-support support-REFUTE">REFUTE</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Lipoic acid supplementation has not led to significant clinical improvement."</div>
                
                
                <div class="evidence-explanation">Fourth case confirms ineffectiveness of lipoic acid supplementation in LIPT2 deficiency.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">ðŸ”¬</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Decreased protein lipoylation
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(INCREASED)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28757203" target="_blank">PMID:28757203</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-IN_VITRO">In Vitro</span>
                    
                </div>
                
                <div class="evidence-snippet">"Affected individuals&#39; fibroblasts showed reduced oxygen consumption rates, PDHc, Î±-KGDHc activities, leucine catabolic flux, and decreased protein lipoylation."</div>
                
                
                <div class="evidence-explanation">Western blot analysis of patient fibroblasts showed decreased lipoylation of E2 subunits, providing a functional biomarker.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Reduced PDHc activity
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(INCREASED)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28757203" target="_blank">PMID:28757203</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-IN_VITRO">In Vitro</span>
                    
                </div>
                
                <div class="evidence-snippet">"Affected individuals&#39; fibroblasts showed reduced oxygen consumption rates, PDHc, Î±-KGDHc activities, leucine catabolic flux, and decreased protein lipoylation."</div>
                
                
                <div class="evidence-explanation">Demonstrates reduced PDHc enzymatic activity as a direct consequence of LIPT2 deficiency.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Reduced alpha-KGDHc activity
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(INCREASED)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28757203" target="_blank">PMID:28757203</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-IN_VITRO">In Vitro</span>
                    
                </div>
                
                <div class="evidence-snippet">"Affected individuals&#39; fibroblasts showed reduced oxygen consumption rates, PDHc, Î±-KGDHc activities, leucine catabolic flux, and decreased protein lipoylation."</div>
                
                
                <div class="evidence-explanation">Demonstrates reduced alpha-KGDHc activity as part of the combined dehydrogenase deficiency.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Neonatal Severe Encephalopathy with Lactic Acidosis and Brain
  Abnormalities
creation_date: &#39;2026-02-13T00:59:22Z&#39;
updated_date: &#39;2026-02-17T21:53:14Z&#39;
category: Mendelian
description: &gt;
  NELABA (Encephalopathy, Neonatal Severe, with Lactic Acidosis and Brain
  Abnormalities; OMIM 617668) is an ultra-rare autosomal recessive mitochondrial
  disorder caused by biallelic mutations in LIPT2, encoding lipoyltransferase 2.
  LIPT2 catalyzes the first committed step in the mitochondrial lipoylation
  pathway, transferring octanoyl groups from acyl carrier protein to the glycine
  cleavage system H protein (GCSH). Loss of function impairs lipoylation of all
  lipoic acid-dependent enzyme complexes: pyruvate dehydrogenase, alpha-ketoglutarate
  dehydrogenase, branched-chain ketoacid dehydrogenase, and the glycine cleavage
  system. This causes congenital lactic acidosis, hyperglycinemia, severe
  encephalopathy with minimal psychomotor development, and progressive brain
  abnormalities including cortical atrophy, cysts, white matter abnormalities, and
  cortical malformations. Onset is at birth with hypotonia and respiratory
  insufficiency. Only four cases have been reported. Prognosis is poor; lipoic acid
  supplementation is ineffective.
disease_term:
  preferred_term: NELABA
  term:
    id: MONDO:0060562
    label: encephalopathy, neonatal severe, with lactic acidosis and brain
      abnormalities
parents:
- Mitochondrial lipoylation defect
- Neonatal encephalopathy
inheritance:
- name: Autosomal recessive
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: &gt;
    NELABA follows autosomal recessive inheritance. Affected individuals carry
    biallelic (homozygous or compound heterozygous) loss-of-function mutations
    in LIPT2. Three initial patients from two families were reported with compound
    heterozygous mutations.
  evidence:
  - reference: PMID:28757203
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;We report on the identification of biallelic LIPT2 mutations in three
      affected individuals from two families with severe neonatal encephalopathy.&#34;
    explanation: Establishes autosomal recessive inheritance pattern with
      biallelic mutations in two unrelated families.
pathophysiology:
- name: Impaired mitochondrial lipoylation via LIPT2 deficiency
  description: &gt;
    LIPT2 encodes lipoyltransferase 2, which transfers octanoyl groups from
    octanoyl-ACP (synthesized by the mitochondrial fatty acid synthesis system) to
    the glycine cleavage system H protein (GCSH). This is the first committed step
    in the mitochondrial lipoylation pathway. The octanoyl-GCSH is then converted
    to lipoyl-GCSH by lipoic acid synthetase (LIAS), and LIPT1 relays lipoyl
    groups from GCSH to the E2 subunits of alpha-ketoacid dehydrogenases.
    Loss-of-function mutations in LIPT2 abolish this initial transfer, leading
    to deficient lipoylation of all lipoic acid-dependent enzyme complexes and
    disruption of the glycine cleavage system. Unlike LIPT1 deficiency which
    spares glycine cleavage, LIPT2 deficiency affects all lipoylated proteins.
  genes:
  - preferred_term: LIPT2
    term:
      id: hgnc:37216
      label: LIPT2
  gene:
    preferred_term: LIPT2
    description: Lipoyltransferase 2, catalyzes the first committed step in
      mitochondrial lipoylation by transferring octanoyl groups from
      octanoyl-ACP to GCSH.
    modifier: DECREASED
    term:
      id: hgnc:37216
      label: LIPT2
  cell_types:
  - preferred_term: Neuron
    term:
      id: CL:0000540
      label: neuron
  biological_processes:
  - preferred_term: Protein lipoylation
    term:
      id: GO:0009249
      label: protein lipoylation
  downstream:
  - target: Combined alpha-ketoacid dehydrogenase deficiency
    description: Loss of lipoylation impairs PDHc, alpha-KGDHc, and BCKDHc E2
      subunits.
    causal_link_type: DIRECT
  - target: Glycine cleavage system dysfunction
    description: Failure to lipoylate GCSH directly impairs glycine cleavage
      activity.
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:28757203
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Affected individuals&#39; fibroblasts showed reduced oxygen consumption
      rates, PDHc, Î±-KGDHc activities, leucine catabolic flux, and decreased protein
      lipoylation.&#34;
    explanation: Demonstrates that LIPT2 mutations cause decreased protein
      lipoylation and impaired function of multiple mitochondrial enzyme
      complexes in patient fibroblasts.
  - reference: PMID:28757203
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: &#34;A normalization of lipoylation was observed after expression of wild-type
      LIPT2, arguing for LIPT2 requirement in intramitochondrial lipoate synthesis.&#34;
    explanation: Wild-type LIPT2 complementation rescues lipoylation defect,
      confirming LIPT2 as the causative gene.
  - reference: PMID:32508887
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: &#34;LIPT2 utilizes octanoyl-ACP synthesized by the mitochondrial fatty acid
      synthesis system to modify GCSH.&#34;
    explanation: Review defining the biochemical role of LIPT2 as the enzyme
      that transfers octanoyl groups to the glycine cleavage system H protein.
- name: Combined alpha-ketoacid dehydrogenase deficiency
  description: &gt;
    Defective lipoylation of the E2 subunits of pyruvate dehydrogenase (PDHc),
    alpha-ketoglutarate dehydrogenase (alpha-KGDHc), and branched-chain ketoacid
    dehydrogenase (BCKDHc) impairs oxidative metabolism of pyruvate, alpha-ketoglutarate,
    and branched-chain amino acids. Loss of PDHc blocks entry of glycolytic end
    products into the TCA cycle, causing pyruvate and lactate accumulation and
    energy failure. Loss of alpha-KGDHc disrupts the TCA cycle at its midpoint.
    The brain is particularly vulnerable due to its high dependence on oxidative
    metabolism.
  biological_processes:
  - preferred_term: Pyruvate dehydrogenase complex
    term:
      id: GO:0045254
      label: pyruvate dehydrogenase complex
  - preferred_term: Tricarboxylic acid cycle
    term:
      id: GO:0006099
      label: tricarboxylic acid cycle
  downstream:
  - target: Lactic acidosis
    description: Blocked oxidative metabolism diverts pyruvate to lactate,
      driving persistent lactic acidemia.
    causal_link_type: DIRECT
  - target: Global developmental delay
    description: Chronic cerebral energy failure impairs neurodevelopment from
      early infancy.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - cerebral energy deficit
    - impaired neuronal maturation
  evidence:
  - reference: PMID:32508887
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: &#34;The loss of these two dehydrogenases short-circuits the citric acid
      cycle, resulting in severe respiratory deficiency and extreme muscle weakness&#34;
    explanation: Review explaining how loss of PDHc and alpha-KGDHc disrupts the
      citric acid cycle and causes the clinical phenotype.
  - reference: PMID:32508887
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: &#34;Patients that display absent or low lipoylation of all three enzymes
      have mutations in either of two genes LIAS or LIPT2&#34;
    explanation: Confirms that LIPT2 mutations affect all three lipoylated
      enzyme complexes.
- name: Glycine cleavage system dysfunction
  description: &gt;
    Unlike LIPT1 deficiency which spares the glycine cleavage system, LIPT2
    deficiency impairs lipoylation of GCSH itself, leading to defective glycine
    cleavage and elevated glycine levels. Glycine accumulation in the brain
    contributes to neurological impairment including seizures and encephalopathy.
  biological_processes:
  - preferred_term: Glycine cleavage complex
    term:
      id: GO:0005960
      label: glycine cleavage complex
  downstream:
  - target: Hyperglycinemia
    description: Reduced glycine cleavage causes systemic glycine accumulation.
    causal_link_type: DIRECT
  - target: Brain glycine accumulation with NMDA receptor overactivation
    description: Glycine accumulation in the CNS increases excitatory
      neurotransmission through NMDA receptor co-agonism.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - elevated brain glycine
    - excitatory neurotransmission imbalance
  evidence:
  - reference: PMID:28757203
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Plasma glycine was mildly increased.&#34;
    explanation: Demonstrates that LIPT2 deficiency impairs the glycine cleavage
      system, unlike LIPT1 deficiency.
  - reference: PMID:32508887
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: &#34;Lack of glycine cleavage activity additionally results in elevated brain
      glycine levels which can result in a host of neurological disorders, including
      neurodegeneration, encephalopathy, and neonatal-onset epilepsy&#34;
    explanation: Review explaining the neurological consequences of impaired
      glycine cleavage in lipoylation defects.
- name: Brain glycine accumulation with NMDA receptor overactivation
  description: &gt;
    Impaired glycine cleavage elevates CNS glycine, which can potentiate
    excitatory neurotransmission through NMDA receptor co-agonism and increase
    cortical network hyperexcitability. This provides a mechanistic bridge from
    glycine cleavage dysfunction to neonatal seizures.
  downstream:
  - target: Seizures
    description: NMDA-mediated network hyperexcitability lowers seizure
      threshold and promotes epileptiform activity.
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:32508887
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: &#34;Lack of glycine cleavage activity additionally results in elevated brain
      glycine levels which can result in a host of neurological disorders, including
      neurodegeneration, encephalopathy, and neonatal-onset epilepsy&#34;
    explanation: Supports elevated brain glycine as the proximal driver of
      neurologic dysfunction, including epilepsy, in lipoylation defects.
phenotypes:
- name: Neonatal hypotonia
  description: &gt;
    Severe hypotonia present from birth, reflecting energy failure in the
    developing nervous system.
  frequency: OBLIGATE
  phenotype_term:
    preferred_term: Neonatal hypotonia
    term:
      id: HP:0001319
      label: Neonatal hypotonia
  evidence:
  - reference: PMID:28757203
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;three affected individuals from two families with severe neonatal encephalopathy&#34;
    explanation: All reported patients presented with severe neonatal
      encephalopathy including hypotonia.
- name: Lactic acidosis
  description: &gt;
    Persistent elevation of serum lactate, pyruvate, and alanine due to impaired
    oxidative metabolism from defective lipoylation of mitochondrial enzyme complexes.
  frequency: OBLIGATE
  phenotype_term:
    preferred_term: Congenital lactic acidosis
    term:
      id: HP:0004902
      label: Congenital lactic acidosis
  evidence:
  - reference: PMID:39536593
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Patient had elevations in lactate (6.1 mmol/L) and glycine.&#34;
    explanation: Fourth reported case confirms lactic acidosis as a consistent
      feature with quantified lactate elevation.
- name: Seizures
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: PMID:28757203
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;three affected individuals from two families with severe neonatal encephalopathy&#34;
    explanation: Seizures are part of the severe neonatal encephalopathy
      described in the index patients.
- name: Cerebral atrophy
  description: &gt;
    Progressive cortical and subcortical atrophy visible on brain MRI.
  phenotype_term:
    preferred_term: Cerebral atrophy
    term:
      id: HP:0002059
      label: Cerebral atrophy
  evidence:
  - reference: PMID:28757203
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Brain MRI showed major cortical atrophy with white matter abnormalities
      and cysts.&#34;
    explanation: Brain MRI in the index patients demonstrated cortical atrophy
      as a consistent feature.
- name: Microcephaly
  phenotype_term:
    preferred_term: Microcephaly
    term:
      id: HP:0000252
      label: Microcephaly
- name: Dystonia
  description: &gt;
    Early-onset severe generalized dystonia is a distinctive feature of LIPT2-related
    disorder, likely due to energy deficit in the developing basal ganglia.
  phenotype_term:
    preferred_term: Dystonia
    term:
      id: HP:0001332
      label: Dystonia
  evidence:
  - reference: PMID:39536593
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Unlike most neurometabolic disorders where dystonia develops later after
      metabolic stroke in basal ganglia, LIPT2-related disorder seems unique due to
      early onset of dystonia due to energy deficit in the developing brain.&#34;
    explanation: The fourth reported case highlights early-onset dystonia as a
      distinctive feature of LIPT2 deficiency.
- name: Spasticity
  phenotype_term:
    preferred_term: Spasticity
    term:
      id: HP:0001257
      label: Spasticity
- name: Delayed myelination
  phenotype_term:
    preferred_term: Delayed myelination
    term:
      id: HP:0012448
      label: Delayed myelination
- name: Global developmental delay
  description: &gt;
    Severe to profound global developmental delay with minimal or absent
    psychomotor development.
  frequency: OBLIGATE
  phenotype_term:
    preferred_term: Profound global developmental delay
    term:
      id: HP:0012736
      label: Profound global developmental delay
  evidence:
  - reference: PMID:39536593
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;The patient was a 15-month-old female who presented at one month with
      dystonia, developmental delay, and feeding difficulties.&#34;
    explanation: Developmental delay is a universal feature across all reported
      LIPT2 patients.
- name: Respiratory insufficiency
  phenotype_term:
    preferred_term: Respiratory insufficiency
    term:
      id: HP:0002093
      label: Respiratory insufficiency
- name: Abnormal cerebral white matter morphology
  description: &gt;
    White matter abnormalities and cystic changes on brain MRI, reflecting
    impaired myelination and energy failure.
  phenotype_term:
    preferred_term: Abnormal cerebral white matter morphology
    term:
      id: HP:0002500
      label: Abnormal cerebral white matter morphology
  evidence:
  - reference: PMID:28757203
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Brain MRI showed major cortical atrophy with white matter abnormalities
      and cysts.&#34;
    explanation: Brain MRI in index patients demonstrated white matter
      abnormalities as a consistent feature.
- name: Hyperglycinemia
  description: &gt;
    Mildly elevated plasma glycine due to impaired glycine cleavage system
    function from defective GCSH lipoylation. Distinguishes LIPT2 deficiency
    from LIPT1 deficiency, which spares the glycine cleavage system.
  phenotype_term:
    preferred_term: Hyperglycinemia
    term:
      id: HP:0002154
      label: Hyperglycinemia
  evidence:
  - reference: PMID:28757203
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Plasma glycine was mildly increased.&#34;
    explanation: Elevated glycine reflects impaired glycine cleavage system
      lipoylation in LIPT2 deficiency.
  - reference: PMID:39536593
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Patient had elevations in lactate (6.1 mmol/L) and glycine.&#34;
    explanation: Fourth case confirms glycine elevation as a biochemical marker
      of LIPT2 deficiency.
- name: Polymicrogyria
  description: &gt;
    Cortical malformation reported in the fourth case, expanding the phenotypic
    spectrum of LIPT2-related disorder.
  phenotype_term:
    preferred_term: Polymicrogyria
    term:
      id: HP:0002126
      label: Polymicrogyria
  evidence:
  - reference: PMID:39536593
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Brain magnetic resonance imaging showed cortical malformations including
      colpocephaly, polymicrogyria, and heterotopia.&#34;
    explanation: Brain MRI in the fourth case revealed cortical malformations
      not previously described in LIPT2 deficiency.
- name: Feeding difficulties
  phenotype_term:
    preferred_term: Feeding difficulties in infancy
    term:
      id: HP:0008872
      label: Feeding difficulties in infancy
  evidence:
  - reference: PMID:39536593
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;The patient was a 15-month-old female who presented at one month with
      dystonia, developmental delay, and feeding difficulties.&#34;
    explanation: Feeding difficulties reported in the fourth case.
biochemical:
- name: Decreased protein lipoylation
  presence: INCREASED
  notes: Detected by anti-lipoic acid antibody immunoblotting in patient
    fibroblasts
  evidence:
  - reference: PMID:28757203
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: &#34;Affected individuals&#39; fibroblasts showed reduced oxygen consumption
      rates, PDHc, Î±-KGDHc activities, leucine catabolic flux, and decreased protein
      lipoylation.&#34;
    explanation: Western blot analysis of patient fibroblasts showed decreased
      lipoylation of E2 subunits, providing a functional biomarker.
- name: Reduced PDHc activity
  presence: INCREASED
  notes: Pyruvate dehydrogenase complex activity reduced in patient fibroblasts
  evidence:
  - reference: PMID:28757203
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: &#34;Affected individuals&#39; fibroblasts showed reduced oxygen consumption
      rates, PDHc, Î±-KGDHc activities, leucine catabolic flux, and decreased protein
      lipoylation.&#34;
    explanation: Demonstrates reduced PDHc enzymatic activity as a direct
      consequence of LIPT2 deficiency.
- name: Reduced alpha-KGDHc activity
  presence: INCREASED
  notes: Alpha-ketoglutarate dehydrogenase complex activity reduced in patient
    fibroblasts
  evidence:
  - reference: PMID:28757203
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: &#34;Affected individuals&#39; fibroblasts showed reduced oxygen consumption
      rates, PDHc, Î±-KGDHc activities, leucine catabolic flux, and decreased protein
      lipoylation.&#34;
    explanation: Demonstrates reduced alpha-KGDHc activity as part of the
      combined dehydrogenase deficiency.
genetic:
- name: LIPT2 loss-of-function variants
  association: Causative
  notes: &gt;
    Biallelic loss-of-function mutations in LIPT2 cause NELABA. The first reported
    mutations were compound heterozygous c.89T&gt;C and c.377T&gt;G. A fourth case
    carried c.346G&gt;T and c.418C&gt;T. Yeast complementation studies confirmed
    pathogenicity.
  evidence:
  - reference: PMID:28757203
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;We report on the identification of biallelic LIPT2 mutations in three
      affected individuals from two families with severe neonatal encephalopathy.&#34;
    explanation: Index report identifying LIPT2 as the causative gene through
      exome sequencing in two families.
  - reference: PMID:39536593
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Exome sequencing showed two variants of uncertain significance in trans
      in the LIPT2 gene: c.346 G&gt;T and c.418C&gt;T.&#34;
    explanation: Fourth case identifies novel LIPT2 variants confirmed by yeast
      complementation.
  - reference: PMID:39536593
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: &#34;Yeast complementation experiments indicate that both patient mutant
      variants result in diminished function versions of the LIPT2 protein.&#34;
    explanation: Functional validation of novel LIPT2 variants in yeast model
      confirms pathogenicity.
treatments:
- name: Supportive care
  description: &gt;
    Management is primarily supportive, including ventilatory support,
    anticonvulsant therapy, and nutritional supplementation. No disease-modifying
    therapy is currently available.
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
- name: Lipoic acid supplementation (ineffective)
  description: &gt;
    Lipoic acid supplementation has been attempted in LIPT2 patients and in
    yeast models but proved ineffective, consistent with the inability of
    exogenous lipoate to be incorporated into the mitochondrial lipoylation
    pathway in mammals.
  evidence:
  - reference: PMID:28757203
    supports: REFUTE
    evidence_source: IN_VITRO
    snippet: &#34;Lipoic acid supplementation did not improve clinical condition nor activities
      of PDHc, Î±-KGDHc, or leucine metabolism in fibroblasts and was ineffective in
      yeast deleted for the orthologous LIP2.&#34;
    explanation: Demonstrates that lipoic acid supplementation does not rescue
      the enzymatic defects in LIPT2 deficiency, either in patient fibroblasts
      or in yeast models.
  - reference: PMID:39536593
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Lipoic acid supplementation has not led to significant clinical improvement.&#34;
    explanation: Fourth case confirms ineffectiveness of lipoic acid
      supplementation in LIPT2 deficiency.
datasets:
references:
- reference: DOI:10.1159/000520553
  title: &#39;A Case with NAD(P)HX Dehydratase (NAXD) Deficiency: A Newly Defined Mutation
    in a Novel Neurodegenerative Disorder&#39;
  findings: []
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/NELABA.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
    <script>
        (function() {
            const banner = document.querySelector('.notice-banner');
            if (!banner) return;
            const dismiss = () => banner.remove();
            banner.addEventListener('click', dismiss);
            banner.addEventListener('keydown', (event) => {
                if (event.key === 'Enter' || event.key === ' ') {
                    event.preventDefault();
                    dismiss();
                }
            });
        })();
    </script>
</body>
</html>